Ayala Pharmaceuticals (AYLA) Stock Analysis

What Ayala Pharmaceuticals does

Ayala Pharmaceuticals, Inc. (AYLA) operates as a clinical-stage oncology firm, concentrating its efforts on discovering, developing, and ultimately commercializing small molecule treatments designed for individuals afflicted by rare and aggressive cancers. A key asset in its pipeline is AL101, an injectable, potent, and highly selective small molecule gamma secretase inhibitor (GSI). This candidate is currently in Phase II clinical trials, specifically targeting recurrent or metastatic adenoid cystic carcinoma in patients whose disease is characterized by Notch-activating mutations. Additionally, the company is advancing AL102, an oral, potent, and selective small molecule GSI, which is undergoing a pivotal Phase II/III study for the management of desmoid tumors. Ayala Pharmaceuticals has also entered into a collaboration agreement with Novartis International Pharmaceutical Limited to explore the development of AL102 for addressing multiple myeloma. The company, founded in 2017, maintains its headquarters in Rehovot, Israel.

Key metrics

ETFs linked to AYLA

Broad-market and Healthcare sector ETFs an investor holding Ayala Pharmaceuticals is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how AYLA fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Ayala Pharmaceuticals?

Ayala Pharmaceuticals trades under the ticker AYLA on NASDAQ.

Which exchange is AYLA listed on?

AYLA is listed on NASDAQ.

What sector does Ayala Pharmaceuticals operate in?

Ayala Pharmaceuticals is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze AYLA in a portfolio?

PortView shows AYLA's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.